Lista de obras -

(177)Lu- labeled MOv18 as compared to (131)I- or (90)Y-labeled MOv18 has the better therapeutic effect in eradication of alpha folate receptor-expressing tumor xenografts.

artículo científico publicado en 2009

111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.

artículo científico publicado en 2003

111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.

artículo científico publicado en 2010

131I/123I-metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour imaging

artículo científico publicado en 2003

131I/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging

artículo científico publicado en 2010

67Ga scintigraphy: procedure guidelines for tumour imaging.

artículo científico publicado en 2003

90Y Labeling of monoclonal antibody MOv18 and preclinical validation for radioimmunotherapy of human ovarian carcinomas

artículo científico publicado en 2005

A female survivor of childhood medulloblastoma presenting with growth-hormone-induced edema and inflammatory lesions: a case report

artículo científico publicado en 2009

Abundant in vitro expression of the oncofetal ED-B-containing fibronectin translates into selective pharmacodelivery of (131)I-L19SIP in a prostate cancer patient

artículo científico publicado en 2013

Antitumor effects of a human dimeric antibody fragment 131I-AFRA-DFM5.3 in a mouse model for ovarian cancer

artículo científico publicado en 2011

Assessing anti-cancer treatment by positron emission tomography: primum non nocere.

artículo científico publicado en 2004

Bone scintigraphy: procedure guidelines for tumour imaging

artículo científico publicado en 2003

Bone turnover markers and insulin-like growth factor components in metastatic breast cancer: results from a randomised trial of exemestane vs megestrol acetate

artículo científico publicado en 2003

Breast scintigraphy: procedure guidelines for tumour imaging

artículo científico publicado en 2003

Clinical results and economic considerations of 68Ga-PSMA and radiolabeled choline in prostate cancer.

artículo científico publicado en 2017

Comparison of three different methods for radiolabelling human activated T lymphocytes

Could exemestane affect insulin-like growth factors, interleukin 6 and bone metabolism in postmenopausal advanced breast cancer patients after failure on aminoglutethimide, anastrozole or letrozole?

artículo científico publicado en 2003

Could exemestane affect insulin-like growth factors, interleukin 6 and bone metabolism in postmenopausal advanced breast cancer patients after failure on aminoglutethimide, anastrozole or letrozole?

artículo científico publicado en 2003

Critical aspects of immunoradiometric thyroglobulin assays.

artículo científico publicado en 2003

Diagnostic and therapeutic aspects of iatrogenic hypoparathyroidism

artículo científico publicado en 2003

Diagnostic imaging to detect and evaluate response to therapy in bone metastases from prostate cancer: current modalities and new horizons.

artículo científico publicado en 2016

Diagnostic procedures in the follow-up of patients affected by MEN type 2.

artículo científico publicado en 2003

Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: results and clinical implications after eight-years follow-up.

artículo científico publicado en 2014

Dosimetry in myeloablative (90)Y-labeled ibritumomab tiuxetan therapy: possibility of increasing administered activity on the base of biological effective dose evaluation. Preliminary results.

artículo científico publicado en 2007

EANM procedure guideline for radio-immunotherapy for B-cell lymphoma with 90Y-radiolabelled ibritumomab tiuxetan (Zevalin)

artículo científico publicado en 2007

Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study

artículo científico publicado en 2017

Effective treatment of bone metastases from a neuroendocrine tumour of the pancreas with high activities of Indium-111-pentetreotide

artículo científico publicado en 2003

Evaluation of circulating calcitonin: analytical aspects.

artículo científico publicado en 2003

FDG-PET for axillary lymph node staging in primary breast cancer

artículo científico publicado en 2004

FDG-PET in thyroid cancer.

artículo científico publicado en 2003

FDG-PET: procedure guidelines for tumour imaging

artículo científico publicado en 2003

Factors Affecting Mortality in 1022 COVID-19 Patients Referred to an Emergency Department in Bergamo during the Peak of the Pandemic

artículo científico publicado en 2020

Feasibility of somatostatin receptor scintigraphy in the detection of occult primary gastro-entero-pancreatic (GEP) neuroendocrine tumours

artículo científico publicado en 2004

High-Dose Myeloablative Zevalin Radioimmunotherapy with Tandem Stem-Cell Autografting Has Promising Activity, Minimal Toxicity and Full Feasibility in an Outpatient Setting. ⬇️

scholarly article

High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantation.

artículo científico publicado en 2008

In Reply

Incident pain and analgesic consumption decrease after samarium infusion: a pilot study

artículo científico publicado en 2006

Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?

artículo científico publicado en 2013

Key elements of preparedness for pandemic coronavirus disease 2019 (COVID-19) in nuclear medicine units

artículo científico publicado en 2020

Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM.

artículo científico publicado en 2013

Matched pairs dosimetry: 124I/131I metaiodobenzylguanidine and 124I/131I and 86Y/90Y antibodies

scientific article published on 12 April 2011

New perspectives in the treatment of neuroendocrine tumours

artículo científico

Nuclear medicine and the revolution in the modern management of castration-resistant prostate cancer patients: from (223)Ra-dichloride to new horizons for therapeutic response assessment.

artículo científico publicado en 2015

Prognostic and predictive role of [18 F]fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with unresectable malignant pleural mesothelioma (MPM) treated with up-front pemetrexed-based chemotherapy.

artículo científico publicado en 2017

Progress and challenges in neuroendocrine and neural crest tumours: molecular imaging and therapy.

artículo científico publicado en 2009

Prostate-specific antigen and radiolabelled choline PET/CT for the assessment of response to therapy: synergy or conflicting?

artículo científico publicado en 2015

Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies

artículo científico publicado en 2012

Radioiodine Therapy of Differentiated Thyroid Cancer

Recombinant human thyrotropin (rhTSH) in the follow-up and treatment of patients with thyroid cancer.

artículo científico publicado en 2003

Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival.

artículo científico publicado en 2006

Sentinel lymph node detection following the hysteroscopic peritumoural injection of 99mTc-labelled albumin nanocolloid in endometrial cancer.

artículo científico publicado en 2004

Sentinel node in breast cancer procedural guidelines

scientific article published on 01 December 2007

Serum Markers of Bone Metastases in Postmenopausal Breast Cancer Patients Treated with Formestane

artículo científico publicado el 1 de enero de 1997

Simple preparation and purification of ethanol-free solutions of 3'-deoxy-3'-[18F]fluorothymidine by means of disposable solid-phase extraction cartridges

artículo científico publicado en 2011

Single-photon emission computed tomography tracers in the diagnostics of neuroendocrine tumors

artículo científico publicado en 2013

Somatostatin receptor SPECT.

artículo científico publicado en 2012

Somatostatin receptor scintigraphy for bronchial carcinoid follow-up

artículo científico publicado en 2003

The estrogen suppression after sequential treatment with formestane in advanced breast cancer patients

artículo científico publicado en 2004

The future of choline pet in the era of PMSA.

artículo científico publicado en 2018

The role of radionuclide therapy in medullary thyroid cancer.

artículo científico publicado en 2003

Thyroid-stimulating hormone suppression for protection against hypothyroidism due to craniospinal irradiation for childhood medulloblastoma/primitive neuroectodermal tumor

artículo científico publicado en 2007

Update on the treatment of neuroendocrine tumors ⬇️

artículo científico publicado el 1 de octubre de 2003

Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study

scholarly article by Vincenzo Mazzaferro et al published 22 March 2013 in Hepatology

¹⁸F-FLT PET/CT as an imaging tool for early prediction of pathological response in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy: a pilot study.

artículo científico publicado en 2015

Lista de obras de

(177)Lu- labeled MOv18 as compared to (131)I- or (90)Y-labeled MOv18 has the better therapeutic effect in eradication of alpha folate receptor-expressing tumor xenografts.

111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.

111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.

131I/123I-metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour imaging

131I/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging

67Ga scintigraphy: procedure guidelines for tumour imaging.

90Y Labeling of monoclonal antibody MOv18 and preclinical validation for radioimmunotherapy of human ovarian carcinomas

A female survivor of childhood medulloblastoma presenting with growth-hormone-induced edema and inflammatory lesions: a case report

Abundant in vitro expression of the oncofetal ED-B-containing fibronectin translates into selective pharmacodelivery of (131)I-L19SIP in a prostate cancer patient

Antitumor effects of a human dimeric antibody fragment 131I-AFRA-DFM5.3 in a mouse model for ovarian cancer

Assessing anti-cancer treatment by positron emission tomography: primum non nocere.

Bone scintigraphy: procedure guidelines for tumour imaging

Bone turnover markers and insulin-like growth factor components in metastatic breast cancer: results from a randomised trial of exemestane vs megestrol acetate

Breast scintigraphy: procedure guidelines for tumour imaging

Clinical results and economic considerations of 68Ga-PSMA and radiolabeled choline in prostate cancer.

Comparison of three different methods for radiolabelling human activated T lymphocytes

Could exemestane affect insulin-like growth factors, interleukin 6 and bone metabolism in postmenopausal advanced breast cancer patients after failure on aminoglutethimide, anastrozole or letrozole?

Could exemestane affect insulin-like growth factors, interleukin 6 and bone metabolism in postmenopausal advanced breast cancer patients after failure on aminoglutethimide, anastrozole or letrozole?

Critical aspects of immunoradiometric thyroglobulin assays.

Diagnostic and therapeutic aspects of iatrogenic hypoparathyroidism

Diagnostic imaging to detect and evaluate response to therapy in bone metastases from prostate cancer: current modalities and new horizons.

Diagnostic procedures in the follow-up of patients affected by MEN type 2.

Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: results and clinical implications after eight-years follow-up.

Dosimetry in myeloablative (90)Y-labeled ibritumomab tiuxetan therapy: possibility of increasing administered activity on the base of biological effective dose evaluation. Preliminary results.

EANM procedure guideline for radio-immunotherapy for B-cell lymphoma with 90Y-radiolabelled ibritumomab tiuxetan (Zevalin)

Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study

Effective treatment of bone metastases from a neuroendocrine tumour of the pancreas with high activities of Indium-111-pentetreotide

Evaluation of circulating calcitonin: analytical aspects.

FDG-PET for axillary lymph node staging in primary breast cancer

FDG-PET in thyroid cancer.

FDG-PET: procedure guidelines for tumour imaging

Factors Affecting Mortality in 1022 COVID-19 Patients Referred to an Emergency Department in Bergamo during the Peak of the Pandemic

Feasibility of somatostatin receptor scintigraphy in the detection of occult primary gastro-entero-pancreatic (GEP) neuroendocrine tumours

High-Dose Myeloablative Zevalin Radioimmunotherapy with Tandem Stem-Cell Autografting Has Promising Activity, Minimal Toxicity and Full Feasibility in an Outpatient Setting. ⬇️

High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantation.

In Reply

Incident pain and analgesic consumption decrease after samarium infusion: a pilot study

Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?

Key elements of preparedness for pandemic coronavirus disease 2019 (COVID-19) in nuclear medicine units

Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM.

Matched pairs dosimetry: 124I/131I metaiodobenzylguanidine and 124I/131I and 86Y/90Y antibodies

New perspectives in the treatment of neuroendocrine tumours

Nuclear medicine and the revolution in the modern management of castration-resistant prostate cancer patients: from (223)Ra-dichloride to new horizons for therapeutic response assessment.

Prognostic and predictive role of [18 F]fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with unresectable malignant pleural mesothelioma (MPM) treated with up-front pemetrexed-based chemotherapy.

Progress and challenges in neuroendocrine and neural crest tumours: molecular imaging and therapy.

Prostate-specific antigen and radiolabelled choline PET/CT for the assessment of response to therapy: synergy or conflicting?

Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies

Radioiodine Therapy of Differentiated Thyroid Cancer

Recombinant human thyrotropin (rhTSH) in the follow-up and treatment of patients with thyroid cancer.

Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival.

Sentinel lymph node detection following the hysteroscopic peritumoural injection of 99mTc-labelled albumin nanocolloid in endometrial cancer.

Sentinel node in breast cancer procedural guidelines

Serum Markers of Bone Metastases in Postmenopausal Breast Cancer Patients Treated with Formestane

Simple preparation and purification of ethanol-free solutions of 3'-deoxy-3'-[18F]fluorothymidine by means of disposable solid-phase extraction cartridges

Single-photon emission computed tomography tracers in the diagnostics of neuroendocrine tumors

Somatostatin receptor SPECT.

Somatostatin receptor scintigraphy for bronchial carcinoid follow-up

The estrogen suppression after sequential treatment with formestane in advanced breast cancer patients

The future of choline pet in the era of PMSA.

The role of radionuclide therapy in medullary thyroid cancer.

Thyroid-stimulating hormone suppression for protection against hypothyroidism due to craniospinal irradiation for childhood medulloblastoma/primitive neuroectodermal tumor

Update on the treatment of neuroendocrine tumors ⬇️

Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study

¹⁸F-FLT PET/CT as an imaging tool for early prediction of pathological response in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy: a pilot study.